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PROPOSITIONS
belonging to the disserta�on en�tled
Reﬁning natural killer cell-based immunotherapy:
Strategies to unleash the killer in a suppressive tumor microenvironment
Niken Miran� Mahaweni
Maastricht, 19 December 2018
1. A suppressive tumor microenvironment is a major setback for NK cell-based immunotherapy and
    needs to be taken into account in the in vitro se�ng. (this disserta�on)
2. Combining a KIR-ligand mismatch donor and an�body-dependent cell-mediated cytotoxicity (ADCC)-
     inducing an�body is one of the powerful strategies to ac�vate all subsets of NK cell. (this disserta�on)
3. The licensing eﬀect of the NKG2A receptor outweighs its inhibitory eﬀect on highly ac�vated NK cells.
    (this disserta�on)
4. Func�onal studies on the new polymorphisms found on the FCGR3A gene would unravel their impact
    on NK-cell’s ADCC and may help the selec�on of NK-cell donors, as well as, the design of clinical
    an�bodies. (this disserta�on)
5. Every type of immune-cell therapy has its own biological strengths and drawbacks, therefore, 
    selec�ng NK cell-, T cell- or Dendri�c cell-based therapy should be based on the immunologic proﬁle
    of the cancer cell and the microenvironment.
6. NK cell-based therapy is highly promising in the clinic because it can be allogeneic and NK cells can be
    manipulated in vitro to target solid tumor, as well as, hematological malignancies in pediatric and adult
    pa�ents. 
7. The cost of cancer care is rising out of control. We have this amazing science, but it’s becoming more
    out of reach.     -Mary C. Beckerle, PhD, director of the Huntsman Cancer Institute, University of Utah-
8. To reduce unnecessary costs for cancer treatment, a personalized tumor mapping and in vitro-
    sensi�vity tes�ng would be necessary to predict the outcome of a cancer therapy.
9. Science is the acceptance of what works and the rejec�on of what does not. That needs more
    courage than we might think.    -Jacob Bronowski, Mathematician & Biologist-
10. A happy world is made up of a happy heart.   -Niken M. Mahaweni- 
